Physician

Richard L Nemec, M.D.

According to 2025 Medicare claims, Richard Nemec, M.D. (NPI: 1659329696) practices gastroenterology in the Winchester, VA-WV market, with the plurality of this provider's patient population coming from Frederick, VA. This provider's primary affiliated billing organization is WINCHESTER GASTROENTEROLOGY ASSOCIATES (NPI: 1740248525; TIN: 541519210) and primary practice location at 22601-2872. Nemec is affiliated with the ACO West Virginia (ACO ID: A3563), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Nemec's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 621 traditional Medicare patients, billed 10,500 HCPCS/CPT codes, and received $250,801 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 526 prescription claims across 183 beneficiaries totaling $401,847 in drug costs, led by Lansoprazole (Lansoprazole). Open Payments data shows 11 records totaling $358. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $211,102 and ending at $250,801. Concurrently, Part D prescription costs have risen steadily, from $101,429 to $401,847. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	798	2,161	$211,102
2016	804	2,992	$191,458
2017	653	1,988	$146,911
2018	773	5,265	$234,131
2019	798	8,120	$307,728
2020	711	8,262	$298,013
2021	614	7,784	$226,544
2022	616	8,240	$236,115
2023	707	12,441	$288,669
2024	621	10,500	$250,801

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	101	387	$101,429
2016	138	459	$85,408
2017	147	433	$100,430
2018	159	479	$59,103
2019	186	580	$202,378
2020	179	587	$114,884
2021	185	562	$113,073
2022	187	566	$144,397
2023	157	496	$254,491
2024	183	526	$401,847

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	178	178	$206
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	140	143	$107
43235	Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope	66	69	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	42	48	$81
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	109	112	$69

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lansoprazole	Lansoprazole	11	810	$12,650
Sucralfate	Sucralfate	37	863	$1,582
Esomeprazole Magnesium	Esomeprazole Magnesium	31	2,302	$1,574
Rabeprazole Sodium	Rabeprazole Sodium	38	1,654	$1,470
Omeprazole	Omeprazole	80	5,718	$1,252

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$358	Salix Pharmaceuticals, a division of Bausch Health US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard L. Nemec, M.D.?

Tedicare shows public-source Medicare data for Richard L. Nemec, M.D. (NPI 1659329696), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard L. Nemec, M.D. have ACO affiliation data?

Richard L. Nemec, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Richard L. Nemec, M.D.?

Richard L. Nemec, M.D. is linked to WINCHESTER GASTROENTEROLOGY ASSOCIATES (billing NPI 1740248525) in the available physician profile data.

Does Richard L. Nemec, M.D. have Open Payments data?

Richard L. Nemec, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.